Healthcare provider profile · identity verified

Wijdan Suwaid, MD

Family Practice · WHEELING, WV · NPI 1780797738

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	648	157
Losartan Potassium	Losartan Potassium	430	107
Levothyroxine Sodium	Levothyroxine Sodium	401	85
Metoprolol Succinate	Metoprolol Succinate	324	87
Amlodipine Besylate	Amlodipine Besylate	308	91
Rosuvastatin Calcium	Rosuvastatin Calcium	278	82
Lisinopril	Lisinopril	274	81
Omeprazole	Omeprazole	263	68
Pantoprazole Sodium	Pantoprazole Sodium	257	70
Potassium Chloride	Potassium Chloride	235	62
Furosemide	Furosemide	197	54
Alendronate Sodium	Alendronate Sodium	169	47
Sertraline Hcl	Sertraline Hcl	166	46
Meloxicam	Meloxicam	158	39
Gabapentin	Gabapentin	157	28
Hydrochlorothiazide	Hydrochlorothiazide	151	48
Famotidine	Famotidine	147	47
Metformin Hcl	Metformin Hcl	142	36
Ozempic	Semaglutide	131	24
Allopurinol	Allopurinol	130	35
Trazodone Hcl	Trazodone Hcl	130	29
Tramadol Hcl	Tramadol Hcl	125	30
Simvastatin	Simvastatin	118	27
Duloxetine Hcl	Duloxetine Hcl	112	31
Metformin Hcl Er	Metformin Hcl	112	32
Glipizide	Glipizide	96	21
Tamsulosin Hcl	Tamsulosin Hcl	85	22
Ezetimibe	Ezetimibe	84	18
Fluticasone Propionate	Fluticasone Propionate	84	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	25
Mounjaro	Tirzepatide	81	14
Tizanidine Hcl	Tizanidine Hcl	79	26
Buspirone Hcl	Buspirone Hcl	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	66	27
Montelukast Sodium	Montelukast Sodium	65	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	57	suppressed
Farxiga	Dapagliflozin Propanediol	52	suppressed
Jardiance	Empagliflozin	52	suppressed
Pravastatin Sodium	Pravastatin Sodium	52	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	suppressed
Carvedilol	Carvedilol	48	13
Methylprednisolone	Methylprednisolone	48	43
Metoprolol Tartrate	Metoprolol Tartrate	48	16
Nystatin	Nystatin	47	15
Pregabalin	Pregabalin	46	suppressed
Eliquis	Apixaban	43	14
Clopidogrel	Clopidogrel Bisulfate	42	12
Escitalopram Oxalate	Escitalopram Oxalate	42	11
Oxybutynin Chloride	Oxybutynin Chloride	42	11
Warfarin Sodium	Warfarin Sodium	42	suppressed
Celecoxib	Celecoxib	41	17
Synthroid	Levothyroxine Sodium	41	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	11
Citalopram Hbr	Citalopram Hydrobromide	38	11
Trulicity	Dulaglutide	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Atenolol	Atenolol	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Bupropion Xl	Bupropion Hcl	33	12
Klor-Con M20	Potassium Chloride	33	11
Prednisone	Prednisone	33	25
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	32	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	15
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Valsartan	Valsartan	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	23
Clonidine Hcl	Clonidine Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	21
Myrbetriq	Mirabegron	25	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Oxazepam	Oxazepam	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Naproxen	Naproxen	19	13
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Cephalexin	Cephalexin	18	16
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Colchicine	Colchicine	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Ramipril	Ramipril	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error